121 related articles for article (PubMed ID: 26392778)
61. Downregulation of hepatoma-derived growth factor activates the Bad-mediated apoptotic pathway in human cancer cells.
Tsang TY; Tang WY; Tsang WP; Co NN; Kong SK; Kwok TT
Apoptosis; 2008 Sep; 13(9):1135-47. PubMed ID: 18651222
[TBL] [Abstract][Full Text] [Related]
62. Down-regulation of HDGF Inhibits the Growth of Hepatocellular Carcinoma Cells In Vitro and In Vivo.
Enomoto H; Nakamura H; Liu W; Iwata Y; Nishikawa H; Takata R; Yoh K; Hasegawa K; Ishii A; Takashima T; Sakai Y; Aizawa N; Ikeda N; Iijima H; Nishiguchi S
Anticancer Res; 2015 Dec; 35(12):6475-9. PubMed ID: 26637859
[TBL] [Abstract][Full Text] [Related]
63. Circulating auto-antibody against hepatoma-derived growth factor (HDGF) in patients with ulcerative colitis.
Nahamura H; Yoshida K; Kishima Y; Enomoto H; Uyama H; Kuroda T; Okuda Y; Hirotani T; Ito H; Kawase I
Hepatogastroenterology; 2004; 51(56):470-5. PubMed ID: 15086185
[TBL] [Abstract][Full Text] [Related]
64. BLM promotes malignancy in PCa by inducing KRAS expression and RhoA suppression via its interaction with HDGF and activation of MAPK/ERK pathway.
Guo Y; Xu H; Huang M; Ruan Y
J Cell Commun Signal; 2023 Sep; 17(3):757-772. PubMed ID: 36574142
[TBL] [Abstract][Full Text] [Related]
65. Vitronectin significantly influences prognosis in osteosarcoma.
Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
[TBL] [Abstract][Full Text] [Related]
66. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
67. Overexpression of hsa_circ_0007534 predicts unfavorable prognosis for osteosarcoma and regulates cell growth and apoptosis by affecting AKT/GSK-3β signaling pathway.
Li B; Li X
Biomed Pharmacother; 2018 Nov; 107():860-866. PubMed ID: 30142548
[TBL] [Abstract][Full Text] [Related]
68. Downregulation of miR-136 promotes the progression of osteosarcoma and is associated with the prognosis of patients with osteosarcoma.
Chu Y; Hu X; Wang G; Wang Z; Wang Y
Oncol Lett; 2019 Jun; 17(6):5210-5218. PubMed ID: 31186737
[TBL] [Abstract][Full Text] [Related]
69. Hepatoma-derived growth factor upregulation is correlated with prognostic factors of early-stage cervical adenocarcinoma.
Tsai CC; Huang SC; Tai MH; Chien CC; Huang CC; Hsu YC
Int J Mol Sci; 2014 Nov; 15(11):21492-504. PubMed ID: 25421244
[TBL] [Abstract][Full Text] [Related]
70. NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth.
Liu S; Zhang Y; Cui S; Song D; Li B; Chen Q; Yao G; Gong B
Cancer Cell Int; 2021 Nov; 21(1):605. PubMed ID: 34774047
[TBL] [Abstract][Full Text] [Related]
71. The evaluation of hepatoma-derived growth factor in determining of prognosis and estimating of invasive probability of tumoral cells, recurrent, and metastasis of lymphatic glands in breast carcinoma.
Kazeminezhad B; Baradaran B; Hafezi Ahmadi MR
J Family Med Prim Care; 2017; 6(4):770-774. PubMed ID: 29564261
[TBL] [Abstract][Full Text] [Related]
72. Tackling FGFR3-driven bladder cancer with a promising synergistic FGFR/HDAC targeted therapy.
Wang Z; Muthusamy V; Petrylak DP; Anderson KS
NPJ Precis Oncol; 2023 Jul; 7(1):70. PubMed ID: 37479885
[TBL] [Abstract][Full Text] [Related]
73. Extracellular vesicle proteomic analysis leads to the discovery of HDGF as a new factor in multiple myeloma biology.
Hoelzinger DB; Quinton SJ; Walters DK; Vardam-Kaur T; Tschumper RC; Borges da Silva H; Jelinek DF
Blood Adv; 2022 Jun; 6(11):3458-3471. PubMed ID: 35395072
[TBL] [Abstract][Full Text] [Related]
74. miR-1254 induced by NESG1 inactivates HDGF/DDX5-stimulated nuclear translocation of β-catenin and suppresses NPC metastasis.
Cheng C; Li W; Peng X; Liu X; Zhang Z; Liu Z; Deng T; Luo R; Fang W; Deng X
Mol Ther Methods Clin Dev; 2021 Mar; 20():615-624. PubMed ID: 33718512
[TBL] [Abstract][Full Text] [Related]
75. Long Non-Coding RNA ASB16-AS1 Functions as a miR-760 Sponge to Facilitate the Malignant Phenotype of Osteosarcoma by Increasing HDGF Expression.
Yin R; Liu J; Zhao D; Wang F
Onco Targets Ther; 2020; 13():2261-2274. PubMed ID: 32214826
[TBL] [Abstract][Full Text] [Related]
76. Downregulation of HDGF inhibits the tumorigenesis of bladder cancer cells by inactivating the PI3K-AKT signaling pathway.
Zhang C; Chang X; Chen D; Yang F; Li Z; Li D; Yu N; Yan L; Liu H; Xu Z
Cancer Manag Res; 2019; 11():7909-7923. PubMed ID: 31692549
[TBL] [Abstract][Full Text] [Related]
77. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.
Zhao C; Li H; Wang L; Sun W
Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496
[TBL] [Abstract][Full Text] [Related]
78. Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
Min X; Wen J; Zhao L; Wang K; Li Q; Huang G; Liu J; Zhao X
Mol Oncol; 2018 Sep; 12(9):1480-1497. PubMed ID: 30004626
[TBL] [Abstract][Full Text] [Related]
79. The expression and clinical significance of HDGF in osteosarcoma.
Chen Z; Qiu S; Lu X
Onco Targets Ther; 2015; 8():2509-17. PubMed ID: 26392778
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
